Policy Notices

• Implementation Details for the NIH Data Management and Sharing Policy
  (NOT-OD-22-189)
  National Institutes of Health
  

• Adjustments to NIH and AHRQ Grant Application Due Dates Between September 22 and September 30, 2022
  (NOT-OD-22-190)
  National Institutes of Health
  Agency for Healthcare Research and Quality
  

General Notices

• Notice of FY2023 Cohort Dates for PAR-22-073, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
  (NOT-CA-22-116)
  National Cancer Institute
  

• Notice of Correction to PAR-22-187, NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
  (NOT-CA-22-118)
  National Cancer Institute
  

• Notice of Correction to PAR-22-188, NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
  (NOT-CA-22-119)
  National Cancer Institute
  

• Notice of Information Webinar for PAR-22-212 "Institutional Research and Academic Career Development Award (IRACDA) (K12)"
  (NOT-GM-22-042)
  National Institute of General Medical Sciences
  

• Notice of Upcoming Prize Competition Announcement for the RADx Tech for Maternal Health Challenge
  (NOT-HD-22-035)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Information: National Institute on Minority Health and Health Disparities (NIMHD) Award to Morehouse School of Medicine Due to Congressional Earmark
  (NOT-MD-22-024)
  National Institute on Minority Health and Health Disparities
  

Notice of Changes to Funding Opportunities

• Notice of Change to NIAMS Acceptance of Diversity Supplement and Re-Entry Supplement Applications
  (NOT-AR-22-024)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Change to add PA-20-195 in NOT-CA-21-121 "Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention"
  (NOT-CA-22-114)
  National Cancer Institute
  

• Notice of Change to Foreign Eligibility and Application Due Date for RFA-HD-23-026 "NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional) "
  (NOT-HD-22-032)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of NINR Participation in PAR-22-181, "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
  (NOT-NR-22-016)
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change to the title of PAR-22-181, "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
  (NOT-NS-22-111)
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  

• Notice of Correction to Award Conditions for NOT-NS-23-001: "Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs"
  (NOT-NS-23-020)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Correction for RFA-OD-22-015: Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed)
  (NOT-OD-22-187)
  Office of Research on Women's Health
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
  (NOT-CA-22-091)
  National Cancer Institute
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation
  (NOT-AI-22-056)
  National Institute of Allergy and Infectious Diseases
  National Institute of Mental Health
  

• Notice of Special Interest (NOSI): HEAL Initiative: Opioid Use Disorder Care Pathways for Individuals with Histories of Exposure to Violence
  (NOT-DA-23-007)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  

• Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes
  (NOT-DA-23-008)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech
  (NOT-NS-23-002)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  

• Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional)
  (NOT-OD-22-142)
  Office of the Director, NIH
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  

Funding Opportunities

• Postbaccalaureate Research Education Program (PREP)(R25 - Independent Clinical Trial Not Allowed)
  (PAR-22-220)
  National Institute of General Medical Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
  (PAR-22-222)
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Application Receipt Date(s): December 07, 2024
  
  

• Alzheimer's-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) (P30 Clinical Trial Optional)
  (RFA-AG-23-025)
  National Institute on Aging
  Application Receipt Date(s): October 21, 2022
  
  

• Resource Centers for Minority Aging Research (RCMAR) (P30 Clinical Trial Optional)
  (RFA-AG-23-026)
  National Institute on Aging
  Application Receipt Date(s): October 21, 2022
  
  

• Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional)
  (RFA-AG-23-027)
  National Institute on Aging
  Application Receipt Date(s): October 21, 2022
  
  

• Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional)
  (RFA-CA-22-019)
  National Cancer Institute
  National Institute of Mental Health
  Application Receipt Date(s): November 08, 2022
  
  

• HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
  (RFA-DA-23-053)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Application Receipt Date(s): March 20, 2024
  
  

• HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
  (RFA-DA-23-054)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Application Receipt Date(s): March 20, 2024
  
  

• Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (R61/R33 - Clinical Trial Not Allowed)
  (RFA-DE-23-006)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): November 09, 2022
  
  

• Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (R42 Fast-Track - Clinical Trial Not Allowed)
  (RFA-DE-23-007)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): November 09, 2022
  
  

• Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (Fast-Track - R44 - Clinical Trial Not Allowed)
  (RFA-DE-23-008)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): November 09, 2022
  
  

• HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R01 Clinical Trial Not Allowed)
  (RFA-DE-23-015)
  National Institute of Dental and Craniofacial Research
  National Center for Complementary and Integrative Health
  National Institute on Drug Abuse
  Application Receipt Date(s): February 14, 2023
  
  

• HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R21 Clinical Trial Not Allowed)
  (RFA-DE-23-016)
  National Institute of Dental and Craniofacial Research
  National Center for Complementary and Integrative Health
  National Institute on Drug Abuse
  Application Receipt Date(s): February 14, 2023
  
  

• NICHD Global Network for Womens and Childrens Health Research: Research Units (UG1 Clinical Trial Optional)
  (RFA-HD-23-008)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 29, 2022
  
  

• NICHD Global Network for Womens and Childrens Health Research: Data Coordinating Center (U24 Clinical Trial Optional)
  (RFA-HD-23-009)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 29, 2022
  
  

• Contraceptive Development Research Center (P50 Clinical Trial Optional)
  (RFA-HD-23-029)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): December 01, 2022
  
  

• Early-Stage Therapy Development for ADRD (R61/R33 Clinical Trial Not Allowed)
  (RFA-NS-22-059)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): October 31, 2022
  
  

• HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional)
  (RFA-NS-23-003)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)
  (RFA-OD-22-014)
  Office of Research on Women's Health
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.